These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25455466)

  • 1. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement.
    Samim M; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Kluin J; Ramjankhan F; Doevendans PA; Stella PR
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):799-805.e1-2. PubMed ID: 25455466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
    Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
    EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
    Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
    EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An embolic deflection device for aortic valve interventions.
    Nietlispach F; Wijesinghe N; Gurvitch R; Tay E; Carpenter JP; Burns C; Wood DA; Webb JG
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1133-8. PubMed ID: 21087748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral events and protection during transcatheter aortic valve replacement.
    Freeman M; Barbanti M; Wood DA; Ye J; Webb JG
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):885-96. PubMed ID: 24550141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk of Cerebral Embolization After Implantation of a Balloon-Expandable Aortic Valve Without Prior Balloon Valvuloplasty.
    Bijuklic K; Haselbach T; Witt J; Krause K; Hansen L; Gehrckens R; Rieß FC; Schofer J
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1608-13. PubMed ID: 26386760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging.
    Arnold M; Schulz-Heise S; Achenbach S; Ott S; Dörfler A; Ropers D; Feyrer R; Einhaus F; Loders S; Mahmoud F; Roerick O; Daniel WG; Weyand M; Ensminger SM; Ludwig J
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1126-32. PubMed ID: 21087747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients.
    Abdul-Jawad Altisent O; Ferreira-Gonzalez I; Marsal JR; Ribera A; Auger C; Ortega G; Cascant P; Urena M; Del Blanco BG; Serra V; Sureda C; Igual A; Rovira A; González-Alujas MT; Gonzalez A; Puri R; Cuellar H; Tornos P; Rodés-Cabau J; Garcia-Dorado D
    Clin Res Cardiol; 2016 Jun; 105(6):508-17. PubMed ID: 26646556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
    JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
    Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
    J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial.
    Haussig S; Mangner N; Dwyer MG; Lehmkuhl L; Lücke C; Woitek F; Holzhey DM; Mohr FW; Gutberlet M; Zivadinov R; Schuler G; Linke A
    JAMA; 2016 Aug; 316(6):592-601. PubMed ID: 27532914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors.
    Samim M; Hendrikse J; van der Worp HB; Agostoni P; Nijhoff F; Doevendans PA; Stella PR
    Clin Res Cardiol; 2015 May; 104(5):430-8. PubMed ID: 25596724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis.
    D'Onofrio A; Rizzoli G; Messina A; Alfieri O; Lorusso R; Salizzoni S; Glauber M; Di Bartolomeo R; Besola L; Rinaldi M; Troise G; Gerosa G
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1065-70; discussion 1070-1. PubMed ID: 24021955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement.
    Lardizabal JA; Macon CJ; O'Neill BP; Desai H; Singh V; Martinez CA; Alfonso CE; Cohen MG; Heldman AW; O'Neill WW; Williams DB
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1226-30. PubMed ID: 25511236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation.
    Van Mieghem NM; El Faquir N; Rahhab Z; Rodríguez-Olivares R; Wilschut J; Ouhlous M; Galema TW; Geleijnse ML; Kappetein AP; Schipper ME; de Jaegere PP
    JACC Cardiovasc Interv; 2015 Apr; 8(5):718-24. PubMed ID: 25946445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
    Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
    EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.
    Nombela-Franco L; del Trigo M; Morrison-Polo G; Veiga G; Jimenez-Quevedo P; Abdul-Jawad Altisent O; Campelo-Parada F; Biagioni C; Puri R; DeLarochellière R; Dumont E; Doyle D; Paradis JM; Quirós A; Almeria C; Gonzalo N; Nuñez-Gil I; Salinas P; Mohammadi S; Escaned J; Fernández-Ortiz A; Macaya C; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1748-57. PubMed ID: 26476610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.